Limerick, Ireland, April 9, 2025 (Globe Newswire) – Kneat.com, Inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a multinational producer of generic pharmaceuticals (“The Company”) has signed a service agreement with Kneat to digitize the drawing management process. Drawing management supports technical and validation processes by digitizing and organizing all technical drawings, eliminating paper -based errors, maintaining the traceability of revisions and controlling access.
The head office is located in Europe and operates more than a dozen production facilities around the world, the company is a leading supplier of generic and biosimilar medicines for patients in more than 100 countries. With more than 20,000 employees, the company will initially use Kneat to manage all its technical drawings on the largest production site in Europe. The company can then use a knee area to streamline and automate all its validation workflows, thereby guaranteeing efficiency, accuracy, data integrity and compliance with good production practices.
“Today’s announcement adds another world leader to our customer community. It also shows the versatility of the Kneat platform, which can be used to deliver extra adjacent functions.”
– Eddie Ryan, Chief Executive Officer of Knat
Strong customer retention has emerged as a determining feature for Knat, because it has grown in the last ten years to become the validation software for the Life Sciences industry, in which the majority of the majority of the top 20 of the greatest life sciences in the world are served. The net turnover retention, which measures the expansion of existing customers for the previous 12 months, was 151% on December 31, 2024. Knat is proud of customer service where 97% of the customers assess it as ‘very good’ or ‘excellent’.
About Kneet
KNAT Solutions offers leading companies in very regulated industries with unparalleled efficiency in validation and compliance through his digital validation platform KNEAT GX. As an industrial leader in customer satisfaction, KNAT has an excellent record for implementation, powered by our user-friendly design, expert support and on-demand training Academy. KNAT GX is a leading digital validation platform with which very regulated companies can manage any validation discipline of end-to-end. KNAT GX is fully ISO 9001 and ISO 27001 certified, fully validated and 21 CFR part 11/Appendix 11 in accordance with. Multiple independent customer studies show up to 40% reduction in documentation cyclist times, up to 20% faster speed to the market and a higher compliance standard.
Warning and future -oriented statements
In addition to the explanations of the historical fact that is included in this, certain information is “future -oriented information” in the sense of applicable Canadian securities laws. Dergelijke toekomstgerichte informatie omvat, maar is niet beperkt tot, de relatie tussen kneat en de klant, de bedrijfsontwikkelingsactiviteiten van KNATE, het gebruik en de implementatietijdlijnen van de software van Kneat in de validatieprocessen van de klant, de mogelijkheid en intentie van de klant om het gebruik van de software van Knat in de organisatie van de klant te schalen in de organisatie van de klant in de organisatie van de klant in de organisatie van de klant in de organisatie van de klant In the organization of the customer and compliance with the Kneat platform under regulatory audit and inspection. Although such future -oriented statements are expressed by Knat, as stated in this release, in good faith and by Knat it is thought that they have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events that are predicted in these future -oriented statements can differ material from actual results or events. These future -oriented statements are not guarantees for future performance, since it entails risks and uncertainties.
KNAT does not accept an obligation to release public revisions to a future -oriented explanation, except as required under applicable securities laws. Investors should not assume that any lack of update of a previously issued future -oriented statement is a reconfirmation of that statement. The constant dependence on future -oriented statements is at the own risk of an investor.
For more information:
Katie Keita, Breat Investor Relations
P: + 1 902-450-2660
E: [email protected]
